Understanding the biological processes that regulate Nf homeostasis in blood, including the endogenous antibody response which clears these proteins from the circulation, is a critical step toward implementing the use of these biomarkers in clinical trials for ALS. Here, NFASC is linked to amyotrophic lateral sclerosis.